Zobrazeno 1 - 10
of 306
pro vyhledávání: '"Gd, Demetri"'
Autor:
Nakamura M, Merchav S, Carter A, Tj, Ernst, Gd, Demetri, Yusuke Furukawa, Anderson K, As, Freedman, Jd, Griffin
Publikováno v:
Europe PubMed Central
Macrophage CSF (M-CSF) induces proliferation of monocyte/macrophage progenitor cells and can also activate some functions of mature cells. Three different human M-CSF cDNA (4.0, 3 to 3.5, and 1.5 kb) which are the result of alternative splicing of th
Autor:
Gd, Demetri, Rs, Benjamin, Cd, Blanke, Jy, Blay, Casali P, Choi H, Cl, Corless, Debiec-Rychter M, Rp, Dematteo, Ds, Ettinger, Ga, Fisher, Cd, Fletcher, Alessandro Gronchi, Hohenberger P, Hughes M, Joensuu H, Judson I, Le Cesne A, Rg, Maki, Morse M, As, Pappo, Pw, Pisters, Cp, Raut, Reichardt P, Ds, Tyler, Ad, Den Abbeele, von Mehren M, Jd, Wayne, Zalcberg J, Nccn, Task Force
Publikováno v:
ResearcherID
Publons
Europe PubMed Central
Publons
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2f49f1d6f32d0a3f2bf9e7bfd76b99c9
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=MEDLINE&KeyUT=MEDLINE:17624289&KeyUID=MEDLINE:17624289
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=MEDLINE&KeyUT=MEDLINE:17624289&KeyUID=MEDLINE:17624289
Autor:
Rodriguez LR; Food and Drug Administration, Silver Spring, MD, United States., Gormley NJ; United States Food and Drug Administration, Silver Spring, MD, United States., Lu R; Alumis, Inc., South San Francisco, CA, United States., Amatya AK; United States Food and Drug Administration, Silver Spring, MD, United States., Demetri GD; Dana-Farber Cancer Institute, Boston, MA, United States., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA, United States., Mesa RA; Wake Forest Baptist Medical Center, Winston-Salem, NC, United States., Pazdur R; United States Food and Drug Administration, Silver Spring, MD, United States., Sekeres MA; Sylvester Comprehensive Cancer Center, Miami, FL, United States., Shan M; Bayer (United States), Whippany, NJ, United States., Snapinn S; Seattle-Quilcene Biostatistics, LLC., Seattle, WA, United States., Theoret MR; Food and Drug Administration, Silver Spring, MD, United States., Umoja R; American Association For Cancer Research, Washington, DC, United States., Vallejo J; United States Food and Drug Administration, Silver Spring, MD, United States., Warren NJH; American Association For Cancer Research, Washington, DC, United States., Xu Q; United States Food and Drug Administration, Silver Spring, MD, United States., Anderson KC; Dana-Farber Cancer Institute, Boston, MA, United States.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jul 22. Date of Electronic Publication: 2024 Jul 22.
Autor:
Cote GM; Center for Sarcoma and Connective Tissue Oncology, Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Haddox CL; Harvard Medical School, Boston, Massachusetts.; Sarcoma Division, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Choy E; Center for Sarcoma and Connective Tissue Oncology, Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Merriam PA; Harvard Medical School, Boston, Massachusetts., Mazzola E; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Venkataraman V; Harvard Medical School, Boston, Massachusetts.; Sarcoma Division, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Alcindor T; Harvard Medical School, Boston, Massachusetts.; Sarcoma Division, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wagner AJ; Harvard Medical School, Boston, Massachusetts.; Sarcoma Division, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Demetri GD; Harvard Medical School, Boston, Massachusetts.; Sarcoma Division, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ludwig Center at Harvard, Boston, Massachusetts.; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, Boston, Massachusetts., George S; Harvard Medical School, Boston, Massachusetts.; Sarcoma Division, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jul 01; Vol. 30 (13), pp. 2702-2708.
Autor:
D'Angelo SP; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. Electronic address: dangelos@mskcc.com., Araujo DM; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Abdul Razak AR; University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada., Agulnik M; City of Hope, Duarte, CA, USA., Attia S; Mayo Clinic, Jacksonville, FL, USA., Blay JY; Centre Léon Bérard, Lyon, France., Carrasco Garcia I; Hospital Virgen del Rocío, Seville, Spain., Charlson JA; Medical College of Wisconsin, Milwaukee, WI, USA., Choy E; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Demetri GD; Dana Farber Cancer Institute, Boston, MA, USA; Ludwig Center at Harvard Medical School, Boston, MA, USA., Druta M; Moffitt Cancer Center, Tampa, FL, USA., Forcade E; Centre Hospitalier Universitaire de Bordeaux-Hôpital Haut-Lévêque, Bordeaux, France., Ganjoo KN; Stanford Cancer Institute, Stanford Medicine at Stanford University, Palo Alto, CA, USA., Glod J; Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA., Keedy VL; Vanderbilt University Medical Center, Nashville, TN, USA., Le Cesne A; Institut Gustave Roussy Cancer Center-DITEP, Villejuif, France., Liebner DA; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Moreno V; START Madrid-FJD, Hospital Universitario Fundación Jiménez Diaz, Madrid, Spain., Pollack SM; Northwestern University, Chicago, IL, USA., Schuetze SM; University of Michigan Health System, Ann Arbor, MI, USA., Schwartz GK; Columbia University Vagelos School of Medicine, New York, NY, USA., Strauss SJ; UCL Cancer Institute, University College London NHS Foundation Trust, London, UK., Tap WD; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA., Thistlethwaite F; The Christie NHS Foundation Trust, Manchester, UK; University of Manchester, Manchester, UK., Valverde Morales CM; Hospital Universitari Vall d'Hebron, Barcelona, Spain., Wagner MJ; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA., Wilky BA; University of Colorado Anschutz Medical Campus, Aurora, CO, USA., McAlpine C; Adaptimmune, Abingdon, UK., Hudson L; Adaptimmune, Abingdon, UK., Navenot JM; Adaptimmune, Philadelphia, PA, USA., Wang T; Adaptimmune, Philadelphia, PA, USA., Bai J; Adaptimmune, Philadelphia, PA, USA., Rafail S; Adaptimmune, Philadelphia, PA, USA., Wang R; Adaptimmune, Abingdon, UK., Sun A; Adaptimmune, Philadelphia, PA, USA., Fernandes L; Adaptimmune, Philadelphia, PA, USA., Van Winkle E; Adaptimmune, Philadelphia, PA, USA., Elefant E; Adaptimmune, Philadelphia, PA, USA., Lunt C; Adaptimmune, Abingdon, UK., Norry E; Adaptimmune, Philadelphia, PA, USA., Williams D; Adaptimmune, Philadelphia, PA, USA., Biswas S; Adaptimmune, Abingdon, UK., Van Tine BA; Washington University School of Medicine, St Louis, MO, USA.
Publikováno v:
Lancet (London, England) [Lancet] 2024 Apr 13; Vol. 403 (10435), pp. 1460-1471. Date of Electronic Publication: 2024 Mar 27.
Autor:
Kummar S; Stanford Cancer Center, Stanford University, Palo Alto, California, USA., Shen L; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China., Hong DS; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., McDermott R; St. Vincent's University Hospital and Cancer Trials Ireland, Dublin, Ireland., Keedy VL; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Casanova M; Paediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Demetri GD; Dana-Farber Cancer Institute and Ludwig Center at Harvard Medical School, Boston, Massachusetts, USA., Dowlati A; University Hospitals Ahuja Medical Center, Beachwood, Ohio, USA., Melcón SG; Pediatric Oncology and Hematology, Vall d'Hebron Children's Hospital, Barcelona, Spain., Lassen UN; Department of Oncology, Rigshospitalet, Copenhagen, Denmark., Leyvraz S; Charité-Universitätsmedizin Berlin, Berlin, Germany., Liu T; Zhongshan Hospital-Fudan University, Shanghai, China., Moreno V; START MADRID-FJD, Hospital Fundación Jiménez Díaz, Madrid, Spain., Patel J; Northwestern University, Chicago, Illinois, USA., Patil T; Department of Medicine, Division of Medical Oncology, University of Colorado, Aurora, Colorado, USA., Mallick AB; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Sousa N; Instituto Portugues de Oncologia do Porto Francisco Gentil, Porto, Portugal., Tahara M; National Cancer Center Hospital East, Kashiwa, Japan., Ziegler DS; Sydney Children's Hospital, Randwick, New South Wales, Australia.; Australia and School of Women's and Children's Health, University of New South Wales Sydney, Sydney, New South Wales, Australia., Norenberg R; Chrestos Concept GmbH & Co. KG, Essen, Germany., Arvis P; Bayer Pharmaceuticals, Loos, France., Brega N; Bayer Pharmaceuticals, Milan, Italy., Drilon A; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Weill Cornell Medical College, New York, New York, USA., Tan DSW; Division of Medical Oncology, National Cancer Centre Singapore, Duke-NUS Medical School, Singapore, Singapore.
Publikováno v:
Cancer [Cancer] 2023 Dec 01; Vol. 129 (23), pp. 3772-3782. Date of Electronic Publication: 2023 Sep 28.
Autor:
Heinrich MC; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Corless CL; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Demetri GD; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Blanke CD; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., von Mehren M; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Joensuu H; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., McGreevey LS; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Chen CJ; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Van den Abbeele AD; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Druker BJ; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Kiese B; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Eisenberg B; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Roberts PJ; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Singer S; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Fletcher CDM; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Silberman S; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Dimitrijevic S; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland., Fletcher JA; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Nov 01; Vol. 41 (31), pp. 4829-4836.
Autor:
Bevill SM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Departments of Cell Biology and Pathology, Harvard Medical School, Boston, MA 02115, USA., Casaní-Galdón S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Departments of Cell Biology and Pathology, Harvard Medical School, Boston, MA 02115, USA., El Farran CA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Departments of Cell Biology and Pathology, Harvard Medical School, Boston, MA 02115, USA., Cytrynbaum EG; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Departments of Cell Biology and Pathology, Harvard Medical School, Boston, MA 02115, USA.; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA., Macias KA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Departments of Cell Biology and Pathology, Harvard Medical School, Boston, MA 02115, USA., Oldeman SE; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Departments of Cell Biology and Pathology, Harvard Medical School, Boston, MA 02115, USA., Oliveira KJ; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Moore MM; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Hegazi E; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Departments of Cell Biology and Pathology, Harvard Medical School, Boston, MA 02115, USA.; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA., Adriaens C; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Departments of Cell Biology and Pathology, Harvard Medical School, Boston, MA 02115, USA., Najm FJ; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Demetri GD; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA 02115, USA., Cohen S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Departments of Cell Biology and Pathology, Harvard Medical School, Boston, MA 02115, USA.; Department of Surgery, Massachusetts General Hospital, Boston, MA 02114, USA., Mullen JT; Department of Surgery, Massachusetts General Hospital, Boston, MA 02114, USA., Riggi N; Department of Cell and Tissue Genomics (CTG), Genentech Inc, South San Francisco, CA 94080, USA., Johnstone SE; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Bernstein BE; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Departments of Cell Biology and Pathology, Harvard Medical School, Boston, MA 02115, USA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA 02115, USA.
Publikováno v:
Cell genomics [Cell Genom] 2023 May 11; Vol. 3 (7), pp. 100321. Date of Electronic Publication: 2023 May 11 (Print Publication: 2023).
Autor:
Neel DV; Harvard Medical School, Boston, Massachusetts, USA., Ma C; Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada., Collins NB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., Hornick JL; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Demetri GD; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute and Ludwig Center at Harvard, Boston, Massachusetts, USA., Shulman DS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2023 Jan; Vol. 12 (1), pp. 170-178. Date of Electronic Publication: 2022 Jun 07.
Autor:
Schaefer IM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. ischaefer@bwh.harvard.edu., Hemming ML; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Sarcoma Center, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Lundberg MZ; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Serrata MP; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Goldaracena I; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Liu N; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Yin P; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Paulo JA; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Gygi SP; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., George S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Sarcoma Center, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Morgan JA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Sarcoma Center, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Bertagnolli MM; Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Sicinska ET; Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Chu C; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA., Zheng S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA., Mariño-Enríquez A; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Hornick JL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Sarcoma Center, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Raut CP; Sarcoma Center, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.; Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Ou WB; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China., Demetri GD; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Sarcoma Center, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA., Saka SK; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.; European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany., Fletcher JA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Sarcoma Center, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.
Publikováno v:
British journal of cancer [Br J Cancer] 2022 Nov; Vol. 127 (11), pp. 2072-2085. Date of Electronic Publication: 2022 Sep 29.